Table 2.
DLQI and PASI comparison between the intervention and control groups.
| Variable | Intervention (n = 42) |
Control (n = 21) |
p-Value *** |
p-Adjusted 1 (Change in Intervention Versus Change in Control Group) |
|---|---|---|---|---|
| PASI, mean (SD) | ||||
| Baseline | 10.0 (1.8) | 8.6 (1.2) | ||
| End of study | 8.1 (2.4) | 8.7 (1.6) | ||
| Change | 1.9 (1.4) | −0.2 (0.6) | <0.001 | |
| p-value * (baseline versus end of trial) | <0.001 | 0.23 | ||
| Adjusted mean | 7.6 | 9.8 | <0.001 | |
| DLQI, mean (SD) | ||||
| Baseline | 7.2 (2.9) | 7.7 (2.9) | ||
| End of study | 5.8 (2.9) | 8.4 (4.1) | ||
| Change | 1.4 (1.0) | −0.7 (2.3) | <0.001 | |
| p-value * (baseline versus end of trial) | <0.001 | 0.19 | ||
| Adjusted mean | 6.0 | 7.9 | <0.001 |
* Paired-samples t-test. *** Independent-samples t-test. 1 Analysis of covariance test adjusted for age, sex, and baseline value of the parameter being evaluated. DLQI, Dermatology Life Quality Index; PASI, Psoriasis Area and Severity Index.